Clinical Trials in Michigan

Showing 181-200 of 12,290 trials

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

IM-1021-101 is a Phase 1 study to determine the safety and effectiveness of IM-1021 in treating participants with advanced cancer.

Solid MalignanciesHematologic Malignancies

Immunome, Inc.117 participantsStarted Feb 2025

Duarte, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +10 more locations

Active Not RecruitingPhase 383 miles

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

NCT05605899

The goal of this clinical study is to compare the study drug, axicabtagene ciloleucel, versus standard of care (SOC) in first-line therapy in participants with high-risk large B-cell lymphoma.

High-risk Large B-cell Lymphoma (LBCL)

Kite, A Gilead Company300 participantsStarted Feb 2023

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Phoenix, Arizona, United States +82 more locations

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

Find Trials by Condition in Michigan

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

BEETroot Juice to Reverse Functional Impairment in PAD

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

SAPIEN 3 Ultra System PMCF